Cessation of smoking

Summary Background People with severe mental illnesses such as schizophrenia are three times more likely to smoke than the wider… Expand

Background Unrestricted by time and place, electronic health (eHealth) provides solutions for patient empowerment and value-based… Expand

This paper aims to provide an in-depth understanding of the attractiveness of e-cigarettes for several different groups. For this… Expand

BACKGROUND The prevalence of smoking has decreased substantially in the United States over the past 30 years. We examined the… Expand

ContextVarenicline, a partial agonist at the α4β2 nicotinic acetylcholine receptor, has the potential to aid smoking cessation by… Expand

Herein we describe a novel series of compounds from which varenicline (1, 6,7,8,9-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3… Expand

Evidence for benefit from nicotine replacement therapy in hospital patients is inconclusive, although the results of a trial… Expand

Abstract Objective and design: To relate UK national trends since 1950 in smoking, in smoking cessation, and in lung cancer to… Expand

BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… Expand

Traditionally smoking cessation studies use smoker and nonsmoker categories almost exclusively to represent individuals quitting… Expand